Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Monitored issues related to drug pricing; issues related to value-based pricing; monitored issues related to Medicaid nonemergency medical transportation; monitored issues related to H.R. 1839, Medicaid Services Investment and Accountability Act of 2019; issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. Monitored issues related to drug pricing and transparency; issues related to gene editing and gene therapy; issues related to value based arrangements; issues related to the Patient Affordability, Value and Efficacy Act (PAVE); issues related to H.R. 2296, FAIR Drug Pricing Act of 2019.
MMM - Medicare/Medicaid HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
EMILY PORTER STACEY HUGHES KATHERINE RAAB STACEY HUGHES EMILY PORTER